Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Epithelial cells which line mucosal surfaces are the first line of defense against bacterial invasion and infection. Recent studies have also indicated that epithelial cells contribute significantly to the orchestration of ongoing inflammatory processes. Here, we demonstrate that human epithelial cells express bactericidal/permeability-increasing protein (BPI), an antibacterial and endotoxin-neutralizing molecule previously associated with neutrophils. Moreover, we demonstrate that such BPI expression is transcriptionally regulated by analogs of endogenously occurring anti-inflammatory eicosanoids (aspirin-triggered lipoxins, ATLa). Initial studies to verify microarray analysis revealed that epithelial cells of wide origin (oral, pulmonary, and gastrointestinal mucosa) express BPI and each is similarly regulated by aspirin-triggered lipoxins. Studies aimed at localization of BPI revealed that such expression occurs on the cell surface of cultured epithelial cell lines and dominantly localizes to epithelia in human mucosal tissue. Functional studies employing a BPI-neutralizing anti-serum revealed that surface BPI blocks endotoxin-mediated signaling in epithelia and kills Salmonella typhimurium . These studies identify a previously unappreciated “molecular shield” for protection of mucosal surfaces against Gram-negative bacteria and their endotoxin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [102]
Citations
Cites
Expression monitoring by hybridization to high-density oligonucleotide arrays
Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Norton, H., et al. (1996) · Nature Biotechnology · doi:10.1038/nbt1296-1675 · Cited by 2,840
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Identification of an inducible endothelial-leukocyte adhesion molecule.
Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S., & Gimbrone, M. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9238 · Cited by 1,609
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationCario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,246
Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Pugin, J., Schürer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., & Tobias, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2744 · Cited by 831
Weiss, J., Elsbach, P., Olsson, I., & Odeberg, H. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40872-6 · Cited by 451
McCormick, B. A., Colgan, S. P., Delp-Archer, C., Miller, S. I., & Madara, J. L. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.4.895 · Cited by 447
Self-citationToll receptors in innate immunity
Imler, J.-L., & Hoffmann, J. A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02004-9 · Cited by 432
Research works printed but not linked: 4
- T Ganz, J Weiss Semin Hematol 34, 343–354 (1997).
- R S Cotran, T Mayadas-Norton Pathol Biol 46, 164–170 (1998).
- R B Sartor Inflammatory Bowel Disease, eds J B Kirsner, R J Shorter (Williams & Wilkins, Baltimore), pp. 96–124 (1995).
- M M Haapamaki, J O Haggblom, J M Gronroos, E Pekkala, K Alanen, T J Nevalainen Hepato-Gastroenterology 46, 2273–2277 (1999).
Cited by
Items 101–200 of 293
Lipoxins and lipoxin analogs in asthma
Levy, B. D. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.010 · Cited by 56
Wiese, A., Gutsmann, T., & Seydel, U. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103125001441 · Cited by 57
Schultz, H. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.08.005 · Cited by 56
New insights into lipopolysaccharide inactivation mechanisms in sepsis
Pérez-Hernández, E. G., Delgado-Coello, B., Luna-Reyes, I., & Mas-Oliva, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111890 · Cited by 56
Palmer, C. D., Mancuso, C. J., Weiss, J. P., Serhan, C. N., Guinan, E. C., & Levy, O. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311145 · Cited by 58
“Recent findings showed that ATL increased nonphlogistic phagocytosis of apoptotic PMN by primary human m [8], and can also enhance expression of LPS-neutralizing PBI on human mucosal epithelia [50].”
BackgroundSelf-citationBalakrishnan, A., Marathe, S. A., Joglekar, M., & Chakravortty, D. (2012) · Innate Immunity · doi:10.1177/1753425912465098 · Cited by 54
“Aspirintriggered lipoxin (ATLa), an analogue of antiinflammatory eicosanoid lipoxin A4 (LXA4) upregulated BPI expression in epithelial (Caco-2) cells.(51) Microarray studies in antrum and gastric mucosal samples of Helicobacter pylori-infected individuals have revealed that the BPI gene is upregulated (13.”
BackgroundPilonieta, M. C., Erickson, K. D., Ernst, R. K., & Detweiler, C. S. (2009) · Journal of Bacteriology · doi:10.1128/jb.00688-09 · Cited by 56
“In Vibrio cholerae, the porin, OmpU, has been implicated in bacterial resistance to multiple stressors, including polymyxin B, organic acids, and bactericidal/permeability-increasing protein (a 55- to 60-kDa protein on the surface of human gastrointestinal tract epithelial cells) (12, 43, 45, 66).”
BackgroundNoguchi, T., Shiba, H., Komatsuzawa, H., Mizuno, N., Uchida, Y., Ouhara, K., Asakawa, R., Kudo, S., Kawaguchi, H., Sugai, M., et al. (2003) · Inflammation · doi:10.1023/b:ifla.0000006702.27906.e9 · Cited by 54
“The expression of bactericidal/permeabilityincreasing protein, an antibacterial and endotoxinneutralizing molecule in human mucosal epithelia is transcriptionally regulated by Lipoxins derived from membrane arachidonic acid (44).”
BackgroundLipoxins: Pro-resolution lipid mediators in intestinal inflammation
Goh, J., Godson, C., Brady, H. R., & MacMathúna, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50154 · Cited by 60
Proteomic Analysis of Pure Human Airway Gland Mucus Reveals a Large Component of Protective Proteins
Joo, N. S., Evans, I. A. T., Cho, H.-J., Park, I.-H., Engelhardt, J. F., & Wine, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116756 · Cited by 54
“BPI proteins have selective anti-microbial actions against Gram negative bacteria [43,44], and A1/SPLUNC1 has potent anti-proteolytic activity that endogenously regulates ENaC in airways [45] in a manner that should increase the volume of ASL.”
BackgroundThe Inflammatory Tissue Microenvironment in IBD
Colgan, S. P., Curtis, V. F., & Campbell, E. L. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcaaf · Cited by 57
Self-citationJiang, K., Guo, S., Yang, J., Liu, J., Shaukat, A., Zhao, G., Wu, H., & Deng, G. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.033 · Cited by 50
Zhang, Y., He, X., Li, X., Fu, D., Chen, J., & Yu, Z. (2011) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2011.01.031 · Cited by 52
Defensins and Other Antimicrobial Peptides and Proteins
Lehrer, R. I., Bevins, C. L., & Ganz, T. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50010-3 · Cited by 62
“More recently, BPI was also identified as a component of human eosinophil granules and as a lipoxin-inducible protein in mucosal epithelia (Canny et al.”
BackgroundEndogenous Receptor Agonists: Resolving Inflammation
Bannenberg, G., Arita, M., & Serhan, C. N. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.188 · Cited by 47
“The aspirin-triggered lipoxin analogs also potently activate the formation in epithelial cells of the microbicidal and opsonizing protein bactericidalpermeability inducing protein[101].”
BackgroundSelf-citationLevy, B. D., Zhang, Q. Y., Bonnans, C., Primo, V., Reilly, J. J., Perkins, D. L., Liang, Y., Arnaout, M. A., Nikolic, B., & Serhan, C. N. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.09.002 · Cited by 50
Self-citationRuíz, A., Sarabia‐Cobo, C., Torres, M., & Juárez, E. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105694 · Cited by 46
Canny, G., Cario, E., Lennartsson, A., Gullberg, U., Brennan, C., Levy, O., & Colgan, S. P. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00347.2005 · Cited by 50
“Charles Serhan), a molecule we (4) have previously demonstrated to increase epithelial BPI mRNA, significantly induced the 222-bp promoter (P 0.”
InfluentialSelf-citationAntimicrobial Peptides in Gastrointestinal Inflammation
Jäger, S., Stange, E. F., & Wehkamp, J. (2010) · International Journal of Inflammation · doi:10.4061/2010/910283 · Cited by 53
“Its sphere of action covers mostly Gram-negative bacteria [28, 29].”
BackgroundCanny, G., Trifonova, R. T., Kindelberger, D. W., Colgan, S. P., & Fichorova, R. N. (2006) · The Journal of Infectious Diseases · doi:10.1086/505712 · Cited by 44
“of adherent epithelial cells over a time course of 45 min (cited in [2, 6]) demonstrated that both endocervical and ectocervical”
BackgroundSelf-citationLi, J., Qiu, H., Gong, H., & Tong, W. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00551 · Cited by 43
Nuding, S., Gersemann, M., Hosaka, Y., Konietzny, S. A., Schaefer, C., Beisner, J., Schroeder, B. O., Ostaff, M. J., Saigenji, K., Ott, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073867 · Cited by 42
Four Reasons to Consider a Novel Class of Innate Immune Molecules in the Oral Epithelium
LeClair, E. E. (2003) · Journal of Dental Research · doi:10.1177/154405910308201202 · Cited by 43
“However, recent reports (Canny et al., 2002; Levy et al., 2003) have demonstrated expression of BPI in both oral epithelial and intestinal epithelial cell lines.”
BackgroundBaron, O. L., Deleury, E., Reichhart, J., & Coustau, C. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.11.006 · Cited by 40
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon
Zhao, Y., Xue, P., Lin, G., Tong, M., Yang, J., Zhang, Y., Ran, K., Zhuge, D., Yao, Q., & Xu, H. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.02.039 · Cited by 42
Shao, Y., Li, C., Che, Z., Zhang, P., Zhang, W., Duan, X., & Li, Y. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.04.015 · Cited by 44
Interactions between lipopolysaccharide and the intestinal epithelium
Tomlinson, J. E., & Blikslager, A. T. (2004) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2004.224.1446 · Cited by 48
Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells
Colgan, S. P., Pitman, R. S., Nagaishi, T., Mizoguchi, A., Mizoguchi, E., Mayer, L. F., Shao, L., Sartor, R. B., Subjeck, J. R., & Blumberg, R. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17241 · Cited by 40
“Characterization of the events that regulate CD1d expression in general, and on the surface of IECs in particular, promises to reveal further information as to the functional role of CD1d.”
ResultSelf-citationLennartsson, A., Pieters, K., Vidovic, K., & Gullberg, U. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304159 · Cited by 40
“In contrast, epithelial and dermal fibroblast cells need appropriate stimulation for expression of BPI [4] [5].”
BackgroundAllam, B., & Espinosa, E. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417186-2.00012-1 · Cited by 51
Canny, G., Swidsinski, A. V., & McCormick, B. A. (2006) · Humana Press eBooks · doi:10.1385/1-59745-113-4:17 · Cited by 39
“We have used this protocol to assess the contribution of BPI to bacterial killing mediated by intestinal epithelial cells but the assay can be adapted for other mucosal epithelial cells using a relevant strain of bacteria.”
BackgroundSelf-citationGao, Y., Zou, J., Chen, B., Cao, Y., Hu, D., Zhang, Y., Zhao, X., Wen, J., Liu, K., & Wang, K. (2022) · Biomaterials Science · doi:10.1039/d2bm01256a · Cited by 38
Aichele, D., Schnare, M., Saake, M., Röllinghoff, M., & Gessner, A. (2006) · Infection and Immunity · doi:10.1128/iai.02066-05 · Cited by 38
“Recently, mucosal epithelia have been shown to be able to produce immune effector molecules, including BPI (3).”
BackgroundToll gates to periodontal host modulation and vaccine therapy
Hajishengallis, G. (2009) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00304.x · Cited by 38
Chien, J. W., Zhao, L. P., Hansen, J. A., Fan, W. H., Parimon, T., & Clark, J. G. (2005) · Blood · doi:10.1182/blood-2005-06-2338 · Cited by 38
Strategic Targets of Essential Host-Pathogen Interactions
Blasi, F., Tarsia, P., & Aliberti, S. (2005) · Respiration · doi:10.1159/000083394 · Cited by 42
“Bactericidal Permeability-Increasing Protein Bactericidal permeability-increasing protein (BPI) is expressed on the cell membranes of human epithelial cells and is an abundant constituent of neutrophils [”
BackgroundBactericidal Permeability-Increasing Proteins Shape Host-Microbe Interactions
Chen, F., Krasity, B. C., Peyer, S. M., Koehler, S., Ruby, E. G., Zhang, X., & McFall‐Ngai, M. (2017) · mBio · doi:10.1128/mbio.00040-17 · Cited by 40
“Despite the differences between isoforms, the bactericidal activity of the BPIs (6), reports of their protective functions in mammalian epithelial tissues (7), and the Received 4 February 2017 Accepted 6 March 2017 Published 4 April 2017”
BackgroundSchinke, S., Fellermann, K., Herlyn, K., Reichel, P. H., Fundke, R., Stange, E. F., Gross, W. L., & Schultz, H. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200411000-00011 · Cited by 36
“BPI represents an additional counterstrategy, as it is not only a potent antibiotic against Gram-negative bacteria and efficiently neutralizes LPS(6) but is also present in the gastrointestinal mucosa either by degranulation of neutrophils(7,29) or secreted by mucosal epithelial cells.(30) In IBD, the mucosal barrier…”
BackgroundInflammation – A New Therapeutic Target in Pneumonia
Cazzola, M., Matera, M. G., & Pezzuto, G. (2005) · Respiration · doi:10.1159/000084039 · Cited by 37
“It also acts as an opsonin for phagocytosis of bacteria by neutrophils [”
BackgroundNovel Pathways and Endogenous Mediators in Anti-Inflammation and Resolution
Serhan, C. N., & Levy, B. D. (2003) · KARGER eBooks · doi:10.1159/000071558 · Cited by 40
Self-citationHiga, L. H., Jerez, H. E., de Farias, M. A., Portugal, R. V., Romero, E. L., & Morilla, M. J. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0437 · Cited by 35
Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis
Vickery, T. W., Armstrong, M., Kofonow, J. M., Robertson, C. E., Kroehl, M., Reisdorph, N. A., Ramakrishnan, V. R., & Frank, D. N. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102218 · Cited by 38
Yan, M., Zhu, L., Wu, S., Cao, Y., Mou, N., Chi, Q., Wang, G., Zhong, Y., & Wu, W. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213126 · Cited by 35
mRNA expression patterns of the BPI/LBP molecule in the Atlantic cod (Gadus morhua L.)
Solstad, T., Stenvik, J., & Jørgensen, T. Ø. (2006) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2006.10.002 · Cited by 36
Bannenberg, G. L. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.57 · Cited by 39
“Also ATL has been shown to stimulate host defense by activating the expression of antibacterial defense such as bactericidal permeability–inducing protein in epithelial cells[312].”
BackgroundXie, H., Lei, N., Gong, A., Chen, X., & Hu, G. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.05.007 · Cited by 35
“Epithelial cells provide the first line of defense against microbial infection at the human mucosal surface [1].”
Wang, L., Yu, M., & Yang, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304101 · Cited by 35
Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium
Chinthamani, S., Odusanwo, O., Mondal, N., Nelson, J. W., Neelamegham, S., & Baker, O. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00259.2011 · Cited by 33
Defensin-immunology in inflammatory bowel disease
Wehkamp, J., Stange, E. F., & Fellermann, K. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(09)73149-5 · Cited by 46
Chiang, S., Veldhuizen, E. J. A., Barnes, F. A., Craven, C. J., Haagsman, H. P., & Bingle, C. D. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.09.013 · Cited by 32
Schultz, H., Schinke, S., Weiss, J. P., Cerundolo, V., Gross, W. L., & Gadola, S. D. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02197.x · Cited by 32
Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions
Theprungsirikul, J., Skopelja‐Gardner, S., & Rigby, W. F. C. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100105 · Cited by 31
“BPI is detectable at the promyelocyte stage of myeloid development [11] and subsequently found in azurophilic granules of neutrophils and to a lesser extent in eosinophils, dermal fibroblasts, macrophages, and certain mucosal epithelial cells [1,12,26–29], although dermal fibroblast and epithelial cells require stimul…”
BackgroundBhatti, G., Romero, R. J., Gomez‐Lopez, N., Chaiworapongsa, T., Jung, E., Gotsch, F., Piqué-Regi, R., Pacora, P., Hsu, C., Kavdia, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04050-9 · Cited by 32
Soory, M. (2010) · Cancers · doi:10.3390/cancers2020670 · Cited by 31
Eckert, M., Wittmann, I., Röllinghoff, M., Gessner, A., & Schnare, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.522 · Cited by 30
“Until recently, the expression of human BPI appeared to be restricted to azurophilic granules of granulocytes, where it is stored as a premade protein; however, it has also been detected in eosinophil granules and most recently in keratinocytes after stimulation with eicosanoids (36).”
BackgroundLevy, O. (2002) · Pediatric Research · doi:10.1203/00006450-200206000-00001 · Cited by 30
Self-citationChoi, E., & Hwang, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002295 · Cited by 33
Schultz, H., Schinke, S., Mosler, K., Herlyn, K., Schuster, A., & Gross, W. L. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.10416 · Cited by 28
“A potential counterstrategy is the bactericidal/permeability-increasing protein that is present in neutrophil granulocytes and mucosal epithelial cells.(21,22) By means of its potent antibiotic and endotoxin-neutralizing abilities, BPI faciliates bacterial clearance and dampens the lipopolysaccharide-triggered inflamm…”
BackgroundUncomplicated Urinary Tract Infection
Bishop, M. C. (2004) · EAU Update Series · doi:10.1016/j.euus.2004.08.003 · Cited by 27
Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop
Dietzold, J., Gopalakrishnan, A., & Salgame, P. (2015) · F1000Prime Reports · doi:10.12703/p7-29 · Cited by 31
“It may also be important to study the effect of lipoxin on non-hematopoietic cells since it induces bactericidal/permeability-increasing protein in human mucosal epithelia [62].”
BackgroundResolvin E1 as a novel agent for the treatment of asthma
Hisada, T., Ishizuka, T., Aoki, H., & Mori, M. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902865622 · Cited by 29
“This is because, in addition to serving as agonists to stop and reduce neutrophil infiltration to inflamed tissues, pro-resolution molecules promote the uptake and clearance of apoptotic cells and microorganisms by macrophages in inflamed sites [33,34], and stimulate the antimicrobial activities of mucosal epithelial…”
BackgroundKoh, E., Hung, C., & Henderson, J. P. (2016) · Infection and Immunity · doi:10.1128/iai.01211-15 · Cited by 28
Zhang, Y., Sun, J., Mu, H., Lun, J. C. Y., & Qiu, J. (2017) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2017.03.047 · Cited by 29
López‐Muñoz, R., Molina‐Berríos, A., Campos‐Estrada, C., Abarca-Sanhueza, P., Urrutia-Llancaqueo, L., Peña-Espinoza, M., & Maya, J. D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01961 · Cited by 27
“Bactericidal/permeability-increasing protein (BPI) is increased in an in vitro model of Salmonella typhimurium infection when LXs are administered (Canny et al., 2002).”
BackgroundDalli, J., Gómez, E. A., & Jouvene, C. C. (2022) · Biomolecules · doi:10.3390/biom12030353 · Cited by 27
“Furthermore, the biology of these molecules extends beyond the regulation of immune cell responses, with several studies detailing the ability of these autacoids in promoting epithelial cell migration [31,32], the production of bactericidal proteins by epithelial cells [33,34] and the regulation of endothelial cell re…”
BackgroundLeClair, E. E., Nomellini, V., Bahena, M., Singleton, V., Bingle, L., Craven, C. J., & Bingle, C. D. (2004) · Genomics · doi:10.1016/j.ygeno.2003.09.015 · Cited by 26
Copy number polymorphisms are not a common feature of innate immune genes
Linzmeier, R. M., & Ganz, T. (2006) · Genomics · doi:10.1016/j.ygeno.2006.03.005 · Cited by 29
Mao, Y., Zhou, C.-Y., Zhu, L., Huang, Y., Yan, T., Fang, J., & Zhu, W. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.05.025 · Cited by 26
Magnusson, M. K., Strid, H., Isaksson, S., Simrén, M., & Öhman, L. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001130 · Cited by 27
AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein
Lennartsson, A., Pieters, K., Ullmark, T., Vidovic, K., & Gullberg, U. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.067 · Cited by 35
“Recently, it was also shown that epithelial cells synthesise BPI [7 BPI is a 55kDa cationic protein with cytotoxic and opsonic activities against Gram-negative bacteria (reviewed in [8] Initial binding of BPI to live bacteria results in a reversible increase of outer membrane permeability and…”
BackgroundSpecialised lipid mediators and their targets
Crean, D., & Godson, C. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.002 · Cited by 27
Reichel, P. H., Seemann, C., Csernok, E., Schröder, J., Müller, A., Gross, W. L., & Schultz, H. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.3.473-475.2003 · Cited by 24
“The bactericidal/permeability-increasing protein (BPI) produced by granulocytes and epithelial cells (3) kills gram-negative bacteria and neutralizes their endotoxin (9, 13).”
BackgroundWATERER, G. W. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.03.003 · Cited by 30
Wermke, M., Maiwald, S., Schmelz, R., Thiede, C., Schetelig, J., Ehninger, G., Bornhäuser, M., & Waßmuth, R. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.06.001 · Cited by 23
BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation
Britto, C. J., Niu, N., Khanal, S., Huleihel, L., Herazo‐Maya, J. D., Thompson, A., Sauler, M., Slade, M. D., Sharma, L., Cruz, C. S. D., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00056.2018 · Cited by 27
The potential of lipid mediator networks as ocular surface therapeutics and biomarkers
Flitter, B. A., Fang, X., Matthay, M. A., & Gronert, K. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.04.008 · Cited by 23
“The actions of SPM in limiting infectious diseases is of considerable interest as they limit collateral damage of activated leukocytes, amplify phagocytosis of bacteria and apoptotic neutrophil, increase formation of bactericidal peptides and increase efficacy of antibiotics [10, 107, 108].”
BackgroundBactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjects
Peuravuori, H. J., Aho, V. V., AHO, H. J., Collan, Y. U., & Saari, K. M. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0062-z · Cited by 23
“to be produced by mucosal epithelial cells [8].”
BackgroundIn vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae
da Silva, A. P., Unks, D., Lyu, S., Ma, J., Zbozien-Pacamaj, R., Chen, X., Krensky, A. M., & Clayberger, C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn058 · Cited by 22
“cholerae must resist many AMPs present in the human intestine, including b-defensins, cathelicidin and BPI.(23,41) An increase in the expression of V.”
BackgroundNasreen, M., Dhouib, R., Hosmer, J., Wijesinghe, H. G. S., Fletcher, A., Mahawar, M., Essilfie, A., Blackall, P. J., McEwan, A. G., & Kappler, U. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00242 · Cited by 20
Contributions of neutrophils to resolution of mucosal inflammation
Colgan, S. P., Ehrentraut, S., Glover, L. E., Kominsky, D. J., & Campbell, E. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8350-2 · Cited by 22
Self-citationBalakrishnan, A., Dassarma, P. A., Bhattacharjee, O., Kim, J., DasSarma, S., & Chakravortty, D. (2016) · Scientific Reports · doi:10.1038/srep33679 · Cited by 20
Yamagata, M., Rook, S. L., Sassa, Y., Ronald, C. W., Geraldes, P., Goddard, L., Clermont, A. C., Gao, B., Salti, H. I., Gundel, R. H., et al. (2006) · The FASEB Journal · doi:10.1096/05-5662com · Cited by 21
“originally identified as a lipopolysaccharide (LPS) binding protein with specific Gram-negative bactericidal activity released from the azurophilic granules of neutrophils (1, 2), is also expressed in epithelial cells in the trachea and the gut ( 3 ).”
BackgroundAntimicrobial host defense in the upper gastrointestinal tract
Hosaka, Y., Koslowski, M. J., Nuding, S., Wang, G., Schlee, M., Schäfer, C., Saigenji, K., Stange, E. F., & Wehkamp, J. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283052ddb · Cited by 19
Microbiota Signals during the Neonatal Period Forge Life-Long Immune Responses
Phillips-Farfán, B. V., Gómez‐Chávez, F., Medina-Torres, E. A., Vargas-Villavicencio, J. A., Carvajal, K., & Camacho, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158162 · Cited by 22
Chiang, N., & Serhan, C. N. (2006) · Comprehensive Therapy · doi:10.1007/s12019-006-0005-6 · Cited by 17
Self-citationGhosh, S., Singh, R., Goap, T. J., Sunnapu, O., Vanwinkle, Z. M., Li, H., Nukavarapu, S. P., Dryden, G. W., Haribabu, B., Vemula, P. K., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02990-8 · Cited by 18
“Inflammatory sites in the intestines comprise of the accumulation of positively charged proteins including transferrin [34], bactericidal/permeability-increasing proteins and antimicrobial peptides [35–37].”
Self-assembled micelle derived from pterostilbene ameliorate acute inflammatory bowel disease
Zhong, H., Zhang, H., Hu, Y., He, S., Qu, H., He, J., Chen, J., Chen, J., Zhang, L., & Deng, C. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122420 · Cited by 18
Palmer, C. D., Guinan, E. C., & Levy, O. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390994 · Cited by 17
Self-citationde Molon, R. S., Thurlings, R. M., Walgreen, B., Helsen, M. M. A., van der Kraan, P. M., Cirelli, J. A., & Koenders, M. I. (2019) · Mediators of Inflammation · doi:10.1155/2019/5689465 · Cited by 18
“This is because proresolution molecules promote uptake and clearance of apoptotic cells as well as microbes by macrophages in inflamed tissue and stimulate antimicrobial activities of cells [22].”
BackgroundThe bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways
Holweg, A., Schnare, M., & Gessner, A. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391045 · Cited by 17
Defensins and Other Antimicrobial Peptides: Innate Defense of Mucosal Surfaces
Cole, A. M., & Ganz, T. (2014) · ASM Press eBooks · doi:10.1128/9781555817619.ch2 · Cited by 16
Balakrishnan, A., & Chakravortty, D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01567 · Cited by 17
“In intestinal epithelial cells, BPI expression is known to be regulated by anti-inflammatory lipid mediator ATLA4 (aspirin-triggered lipoxin A4) (Canny et al., 2002).”
BackgroundMontanari, A., Bergamini, G., Ferrari, A., Ferri, A., Nasi, M., Simonini, R., & Malagoli, D. (2020) · Biology · doi:10.3390/biology9110371 · Cited by 16
“In humans, BPI is stored in the granules of neutrophils and in mucosal epithelial cells [23], it displays opsonizing activity, and its secretion neutralizes LPS inflammatory properties [24].”
BackgroundAntimicrobial peptides and proteins in human biological fluids
Иксанова, А. М., Arzumanian, V. G., Konanykhina, S. Y., & Samoylikov, P. V. (2022) · Microbiology Independent Research Journal (MIR Journal) · doi:10.18527/2500-2236-2022-9-1-37-55 · Cited by 17
Novel approaches to the treatment of pneumonia
Cazzola, M., Matera, M. G., & Page, C. P. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00129-9 · Cited by 16
Novel pH-responsive and CD44-targeting silica nanoparticles for inflammatory bowel disease therapy
Li, W., Cai, J., Gu, Y., Li, X., He, W.-J., Chen, Y., Wang, Z., Li, K., Qin, G., Gu, X., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163017 · Cited by 20
Spinello, A., Cusimano, M. G., Schillaci, D., Inguglia, L., Barone, G., & Arizza, V. (2018) · Marine Drugs · doi:10.3390/md16100366 · Cited by 15
Esophageal human β-defensin expression in eosinophilic esophagitis
Schroeder, S. R., Robinson, Z. D., Masterson, J. C., Hosford, L., Moore, W. R., Pan, Z., Harris, R. F., Souza, R. F., Spechler, S. J., Fillon, S., et al. (2013) · Pediatric Research · doi:10.1038/pr.2013.23 · Cited by 15
“Secreted bicarbonate, mucus, and antimicrobial peptides form integral parts of the innate esophageal mucosal defense mechanisms (1).”
BackgroundSelf-citationEnd-of-life communication in the ICU : a global perspective
Crippen, D. (2008) · Springer eBooks · doi:10.1007/978-0-387-72966-4 · Cited by 10
Structure and Function of Mucosal Surfaces
Pearson, J. P., & Brownlee, I. A. (2014) · ASM Press eBooks · doi:10.1128/9781555817619.ch1 · Cited by 16
Metadata
- Authors
- Canny, G., Levy, O., Furuta, G. T., Narravula-Alipati, S., Sisson, R. B., Serhan, C. N., & Colgan, S. P.
- Affiliations
- University College Dublin (IE)
- Department of Veterinary Physiology, University College of Dublin, Dublin 4, Ireland; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Boston, MA 02115; and Divisions of Infectious Diseases and Pediatric Gastroenterology, Children's Hospital and Harvard Medical School, Boston, MA 02115
- Corresponding author
- Colgan, Sean P.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-03-12
- Volume
- 99
- Issue
- 6
- Pages
- 3902-3907
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122621
- OpenAlex
- W2051793746
- Cited by
- 295
- References
- 49
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 15 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 9 · 2015: 16 · 2014: 12 · 2013: 11 · 2012: 11
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (4r37gm038765-19)
- National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
- National Institute of Allergy and Infectious Diseases (K08AI050583)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050189, R37DK050189, R29DK050189, DK-50189)
- National Institute of Dental and Craniofacial Research (DE13499, P01DE013499)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- bactericidal/permeability-increasing protein, BPI, aspirin-triggered lipoxins, eicosanoids, endotoxin neutralization, lipopolysaccharide signaling, Salmonella typhimurium, antibacterial defense, oral mucosa, gastrointestinal mucosa, transcriptional regulation, Gram-negative bacteria
- MeSH terms
- Anti-Inflammatory Agents, Anti-Bacterial Agents, Blood Proteins, Cell Line, Cell Membrane, Epithelial Cells, Gene Expression Regulation, Humans, Inflammation, Lipids, Lipopolysaccharides, Membrane Proteins, Mucous Membrane, Salmonella typhimurium, Caco-2 Cells, Protein Transport, Antimicrobial Cationic Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.